Avanafil Impurity 23 | CAS 1643811-26-0 - Request Quote
Avanafil Impurity 23
| SZ CAT No: | SZ-A052024 |
| CAS No | 1643811-26-0 |
| Mol.F. | C18H20Cl2N4O4 |
| Mol.Wt. | 427.3 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Avanafil Impurity 23 is chemically (S)-4-((3,5-Dichloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid. Avanafil Impurity 23 is supplied with detailed characterization data compliant with regulatory guideline. Avanafil Impurity 23 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avanafil.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1643811-26-0
Purchase 1643811-26-0
Order 1643811-26-0
Enquire 1643811-26-0
price of 1643811-26-0
1643811-26-0 Supplier
1643811-26-0 Manufacturer
1643811-26-0 Exporter
buy high quality Avanafil Impurity 23
Purchase Avanafil Impurity 23
Avanafil Impurity 23 suppliers
Avanafil Impurity 23 manufacturers
Avanafil Impurity 23 price
Order Avanafil Impurity 23
Enquire Avanafil Impurity 23
Avanafil Impurity 23 cost
Avanafil Impurity 23 Supplier
Avanafil Impurity 23 Distributor
Avanafil Impurity 23 for Method Validation
Avanafil Reference Standard
Avanafil Impurity 23 for ANDA Filing
Avanafil Impurity 23 for Forced Degradation Studies
Avanafil Impurity 23 Identification Standards
Avanafil Impurity 23 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


